Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers

Int J Mol Sci. 2022 Nov 23;23(23):14630. doi: 10.3390/ijms232314630.

Abstract

The aggregation of α-synuclein (α-syn) into neurotoxic oligomers and fibrils is an important pathogenic feature of synucleinopatheis, including Parkinson's disease (PD). A further characteristic of PD is the oxidative stress that results in the formation of aldehydes by lipid peroxidation. It has been reported that the brains of deceased patients with PD contain high levels of protein oligomers that are cross-linked to these aldehydes. Increasing evidence also suggests that prefibrillar oligomeric species are more toxic than the mature amyloid fibrils. However, due to the heterogenous and metastable nature, characterization of the α-syn oligomeric species has been challenging. Here, we generated and characterized distinct α-syn oligomers in vitro in the presence of DA and lipid peroxidation products 4-hydroxy-2-nonenal (HNE) and 4-oxo-2-nonenal (ONE). HNE and ONE oligomer were stable towards the treatment with SDS, urea, and temperature. The secondary structure analysis revealed that only HNE and ONE oligomers contain β-sheet content. In the seeding assay, both DA and ONE oligomers significantly accelerated the aggregation. Furthermore, all oligomeric preparations were found to seed the aggregation of α-syn monomers in vitro and found to be cytotoxic when added to SH-SY5Y cells. Finally, both HNE and ONE α-syn oligomers can be used as a calibrator in an α-syn oligomers-specific ELISA.

Keywords: DA; HNE; ONE; Parkinson’s disease; alpha-synuclein; oligomers.

MeSH terms

  • Amyloid / metabolism
  • Humans
  • Lipid Peroxidation
  • Neuroblastoma*
  • Parkinson Disease* / metabolism
  • alpha-Synuclein / metabolism

Substances

  • alpha-Synuclein
  • Amyloid

Grants and funding

Dr. El-Agnaf laboratory is funded by QBRI project IGP3, HBKU, Qatar Foundation, Doha, Qatar.